At Merck, known as MSD outside of the U.S. and Canada, their purpose is to use the power of leading-edge science to save and improve lives around the world. For more than a century, they’ve been at the forefront of research, bringing forward medicines, vaccines, and innovative health solutions for the world’s most challenging diseases. Merck has supported World Vision’s work for many years, providing grants for critical emergency response work following natural disasters around the world, including 2013’s Typhoon Haiyan in the Philippines, the 2015 earthquake in Nepal, Hurricane Harvey in Texas and Louisiana in 2017, and Hurricane Michael along the Gulf Coast of the U.S. in 2018. Continuing the strong partnership, in 2021 Merck provided a $75,000 grant toward World Vision’s Hurricane Iota relief efforts to help re-roof the homes of hurricane survivors in Colombia. As soon as World Vision’s global COVID-19 response began, faithful partners stepped up to donate supplies and funds for vulnerable children and families. With their support, from the beginning of the pandemic to the end of World Vision’s fiscal year in September 2021, we reached over 66 million people, including nearly 29 million children, in over 70 countries (including the U.S.).
The response included:
- 6.4 million handwashing supplies to support safe hygiene practices
- 11.6 million masks and 5.1 million glove sets to health facilities, health workers, and community members
- Food security assistance to over 8.4 million people
- Over $116 million in loan assistance to support livelihood recovery